C - Chemistry – Metallurgy – 07 – J
Patent
C - Chemistry, Metallurgy
07
J
C07J 13/00 (2006.01) A61K 31/56 (2006.01) A61K 31/565 (2006.01) C07J 1/00 (2006.01) C07J 3/00 (2006.01)
Patent
CA 2165325
The invention relates to a method of altering hypothalamic function in an individual. The method comprises nasally administered a human semiochemical, e.g. an Androstane steroid, or a pharmaceutical composition containing a semiochemical, such that the ligand semiochemical binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or mole pharmaceutically acceptable carriers. Other embodiments of the invention include pharmaceutical compositions containing the steroids.
L'invention concerne un procédé de modification de la fonction hypothalamique chez un individu. Ledit procédé consiste à administrer par voie nasale un produit écomone humain tel qu'un stéroïde d'androstane, ou une composition pharmaceutique contenant un produit écomone, de sorte que le produit écomone ligand se lie à un récepteur neuroépithélial spécifique. Le ou les stéroïdes sont, de préférence, administrés sous forme de composition pharmaceutique contenant un ou plusieurs excipients pharmaceutiquement acceptables. L'invention porte également sur des compositions pharmaceutiques contenant lesdits stéroïdes.
Adams Nathan William
Berliner David L.
Jennings-White Clive L.
Dennison Associates
Pherin Pharmaceuticals Inc.
LandOfFree
Androstane steroids as neurochemical initiators of change in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Androstane steroids as neurochemical initiators of change in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Androstane steroids as neurochemical initiators of change in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1897313